Weight loss in the elderly may be a sign of impending dementia

Archives of Neurology

Volumn 62, Issue 1, 2005, Pages 20-22

  Grundman, Michael ^a  

^a ELAN PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; HYDROCORTISONE; LEPTIN;

ALZHEIMER DISEASE; ANXIETY; APATHY; BRAIN ATROPHY; BRAIN METABOLISM; COGNITIVE DEFECT; COHORT ANALYSIS; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; HUMAN; IRRITABILITY; MEMORY DISORDER; MORTALITY; MULTIINFARCT DEMENTIA; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; DEMENTIA; GERIATRIC ASSESSMENT; HUMANS; MODELS, BIOLOGICAL; WEIGHT LOSS;

EID: 12144283822     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.62.1.20     Document Type: Editorial

References (21)

1. White H, Pieper C, Schmader K. The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis. J Am Geriatr Soc. 1998;46:1223-1227.
2. Stewart R, Masaki K, Xue Q-L, et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol. 2005;62:55-60.
3. Barrett-Connor E, Edelstein SL, Corey-Bloom J, Wiederholt WC. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc. 1996; 44:1147-1152.
4. Nourhashemi F, Deschamps V, Larrieu S, Letenneur L, Dartigues JF, Barberger-Gateau P; PAQUID study. Body mass index and incidence of dementia: the PAQUID study. Neurology. 2003;60:117-119.
5. Borenstein Graves A, Mortimer JA, Bowen JD, et al. Head circumference and incident Alzheimer's disease: modification by apolipoprotein E. Neurology. 2001; 57:1453-1460.
6. Grundman M, Petersen RC, Ferris SH, et al; Alzheimer's Disease Cooperative Study. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004;61:59-66.
7. Feldman H, Scheltens P, Scarpini E, et al. Behavioral symptoms in mild cognitive impairment. Neurology. 2004;62:1199-1201.
8. Jack CR Jr, Petersen RC, Xu Y, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology. 2000;55:484-489.
9. Grundman M, Corey-Bloom J, Jernigan T, Archibald S, Thal LJ. Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy. Neurology. 1996;46:1585-1591.
10. Drevelengas A, Chourmouzi D, Pitsavas G, Charitandi A, Boulogianni G. Reversible brain atrophy and subcortical high signal on MRI in a patient with anorexia nervosa. Neuroradiology. 2001;43:838-840.
11. Katzman DK, Christensen B, Young AR, Zipursky RB. Starving the brain: structural abnormalities and cognitive impairment in adolescents with anorexia nervosa. Semin Clin Neuropsychiatry. 2001;6:146-152.
12. Swayze VW II, Andersen AE, Andreasen NC, Arndt S, Sato Y, Ziebell S. Brain tissue volume segmentation in patients with anorexia nervosa before and after weight normalization. Int J Eat Disord. 2003;33:33-44.
13. Starkman MN, Giordani B, Gebarski SS, Schteingart DE. Improvement in learning associated with increase in hippocampal formation volume. Biol Psychiatry. 2003;53:233-238.
14. Peskind ER, Wilkinson CW, Petrie EC, Schellenberg GD, Raskind MA. Increased CSF cortisol in AD is a function of APOE genotype. Neurology. 2001;56:1094-1098.
15. Vanhanen M, Kivipelto M, Koivisto K, et al. APOE-epsilon4 is associated with weight loss in women with AD: a population-based study. Neurology. 2001;56:655-659.
16. Mayeux R, Honig LS, Tang MX, et al. Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk. Neurology. 2003;61:1185-1190.
17. Intebi AD, Garau L, Brusco I, Pagano M, Gaillard RC, Spinedi E. Alzheimer's disease patients display gender dimorphism in circulating anorectic adipokines Neuroimmunomodulation. 2002-2003;10:351-358.
18. Power DA, Noel J, Collins R, O'Neill D. Circulating leptin levels and weight loss in Alzheimer's disease patients. Dement Geriatr Cogn Disord. 2001;12:167-170.
19. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med. 2003;163:1524-1528.
20. Riviere S, Gillette-Guyonnet S, Voisin T, et al. A nutritional education program could prevent weight loss and slow cognitive decline in Alzheimer's disease. J Nutr Health Aging. 2001;5:295-299.
21. Keller HH, Gibbs AJ, Boudreau LD, Goy RE, Pattillo MS, Brown HM. Prevention of weight loss in dementia with comprehensive nutritional treatment. J Am Geriatr Soc. 2003;51:945-952.